Oncology Nursing News®

Web Exclusives

FDA Lifts Partial Hold on CANOVA Trial for Venetoclax in Myeloma

FDA Lifts Partial Hold on CANOVA Trial for Venetoclax in Myeloma

BY BRIELLE BENYON

How to Measure Real-World Data Against Clinical Trials in Myeloma

How to Measure Real-World Data Against Clinical Trials in Myeloma

BY BRIELLE BENYON

FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer Treatment

FDA Grants Priority Review to Niraparib for Late-Stage Ovarian Cancer Treatment

BY GINA COLUMBUS

FDA Approves Prefilled Syringe for GEP-NETs Treatment

FDA Approves Prefilled Syringe for GEP-NETs Treatment

BY KRISTI ROSA

New Treatments Combat Rising Mortality Rates in Pancreatic Cancer

New Treatments Combat Rising Mortality Rates in Pancreatic Cancer

BY CAROLINE SEYMOUR

Personalized Treatments, Understanding Resistance Help to Improve NSCLC Outcomes

Personalized Treatments, Understanding Resistance Help to Improve NSCLC Outcomes

BY BRIELLE BENYON

Biosimilars: What You Need to Know

Biosimilars: What You Need to Know

BY BRIELLE BENYON

Managing Skin Toxicity From Treatment With Checkpoint Inhibitors in NSCLC

Managing Skin Toxicity From Treatment With Checkpoint Inhibitors in NSCLC

BY KATIE KOSKO

FDA Approves Pembrolizumab for SCLC Treatment

FDA Approves Pembrolizumab for SCLC Treatment

BY BRIELLE BENYON

Pursuing Charlene's Dream

Pursuing Charlene's Dream

BY BRIELLE BENYON

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.